These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 150112)

  • 1. Role of fibrinolysis in development of hyaline membrane disease in newborn rabbits.
    Sueishi K; Tanaka K; Oda T
    Virchows Arch A Pathol Anat Histol; 1978 Jun; 378(3):247-57. PubMed ID: 150112
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of fibrinolytic treatment on rabbit Masugi nephritis.
    Akiba T; Tanaka K
    Acta Pathol Jpn; 1983 Jul; 33(4):773-87. PubMed ID: 6624455
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The fibrinolytic enzyme defect of hyaline membrane disease.
    LIEBERMAN J; KELLOGG F
    Calif Med; 1961 Nov; 95(5):278-82. PubMed ID: 14465183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasminogen activator inhibitor-1 in acute hyperoxic mouse lung injury.
    Barazzone C; Belin D; Piguet PF; Vassalli JD; Sappino AP
    J Clin Invest; 1996 Dec; 98(12):2666-73. PubMed ID: 8981909
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Fibrinolytic acivity in lung tissue from neonates with hyaline membrane disease.
    Ekelund H; Pandolfi M; Ostberg G; Bjernstad A
    Acta Paediatr Scand; 1973 Mar; 62(2):149-57. PubMed ID: 4570825
    [No Abstract]   [Full Text] [Related]  

  • 6. Fibrinolytic activity in the serum of infants with and without the hyaline membrane syndrome.
    SAMARTZIS EA; COOK CD; RUDOLPH AJ
    Acta Paediatr (Stockh); 1960 Nov; 49():727-33. PubMed ID: 13745886
    [No Abstract]   [Full Text] [Related]  

  • 7. Pathways of fibrin turnover in lavage of premature baboons with hyperoxic lung injury.
    Idell S; Kumar A; Koenig KB; Coalson JJ
    Am J Respir Crit Care Med; 1994 Mar; 149(3 Pt 1):767-75. PubMed ID: 8118648
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Extravascular coagulation and fibrin deposition in acute lung injury.
    Idell S
    New Horiz; 1994 Nov; 2(4):566-74. PubMed ID: 7804805
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A deficiency of pulmonary fibrinolysis in hyaline-membrane disease.
    LIEBERMAN J; KELLOGG F
    N Engl J Med; 1960 May; 262():999-1004. PubMed ID: 14416840
    [No Abstract]   [Full Text] [Related]  

  • 10. Effect of fibrinogen degradation products and lung ground substance on surfactant function.
    O'Brodovich HM; Weitz JI; Possmayer F
    Biol Neonate; 1990; 57(6):325-33. PubMed ID: 2142607
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Fibrin degradation products and plasminogen in newborn infants with respiratory disturbances and postnatal asphyxia.
    Ekelund H; Finnström O
    Acta Paediatr Scand; 1972 Nov; 61(6):661-9. PubMed ID: 5080645
    [No Abstract]   [Full Text] [Related]  

  • 12. [Experimental studies on proteolysis of hyaline membranes in vitro (author's transl)].
    Harms D; Buss G; Heimburger N; Pape GR
    Klin Wochenschr; 1975 Dec; 53(24):1147-53. PubMed ID: 1214451
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary plasminogen-activator activity in hyaline membrane disease. A reevaluation on human, bovine, and rabbit fibrin substrates.
    Lieberman J
    Pediatr Res; 1969 Jan; 3(1):11-8. PubMed ID: 5766408
    [No Abstract]   [Full Text] [Related]  

  • 14. Urokinase plasminogen activator released by alveolar epithelial cells modulates alveolar epithelial repair in vitro.
    Van Leer C; Stutz M; Haeberli A; Geiser T
    Thromb Haemost; 2005 Dec; 94(6):1257-64. PubMed ID: 16411403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The artificially ventilated preterm rabbit neonate as experimental model of hyaline membrane disease.
    Nilsson R
    Acta Anaesthesiol Scand; 1982 Apr; 26(2):89-103. PubMed ID: 7048842
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Biochemical and morphological alterations in lungs induced by experimental inhibition of fibrinolytic activity.
    Hoşgör I; Yarat A; Tüzüner N; Alkan F; Emekli N; Ahmad S
    Mol Cell Biochem; 2002 Dec; 241(1-2):9-19. PubMed ID: 12482020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [New theory of fibrinolytic mechanism in the development of hyaline membrane disease in newborn infants].
    Uszyńska-Folejewska R; Uszyński M
    Pediatr Pol; 1975 Dec; 50(12):1513-5. PubMed ID: 127976
    [No Abstract]   [Full Text] [Related]  

  • 18. [Role of hypoxia and hypercapnia in the appearance of hyaline membrane syndrome].
    Mikel'saar RN
    Arkh Patol; 1969; 31(12):47-50. PubMed ID: 5199603
    [No Abstract]   [Full Text] [Related]  

  • 19. Pulmonary ultrastructure in neonatal hyaline membrane disease.
    Lauweryns JM; Bourgeois N
    Arch Dis Child; 1970 Feb; 45(239):146. PubMed ID: 5440188
    [No Abstract]   [Full Text] [Related]  

  • 20. On the pulmonary toxicity of oxygen. 4. The thyroid arena.
    Shanklin DR
    Exp Mol Pathol; 2012 Feb; 92(1):140-54. PubMed ID: 22138105
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.